دورية أكاديمية

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

التفاصيل البيبلوغرافية
العنوان: Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
المؤلفون: Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, MANDALA' M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Schadendorf D
المساهمون: Nathan, P, Ascierto, Pa, Haanen, J, Espinosa, E, Demidov, L, Garbe, C, Guida, M, Lorigan, P, Chiarion-Sileni, V, Gogas, H, Maio, M, Fierro, Mt, Hoeller, C, Terheyden, P, Gutzmer, R, Guren, Tk, Bafaloukos, D, Rutkowski, P, Plummer, R, Waterston, A, Kaatz, M, Mandala', M, Marquez-Rodas, I, Muñoz-Couselo, E, Dummer, R, Grigoryeva, E, Young, Tc, Schadendorf, D
سنة النشر: 2019
المجموعة: IRIS Università degli Studi di Perugia
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000486628600018; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11391/1480919Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070912965
الإتاحة: http://hdl.handle.net/11391/1480919Test
رقم الانضمام: edsbas.174DF92C
قاعدة البيانات: BASE